Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Nutritional shortage augments cisplatin-effects on murine melanoma cells

Texto completo
Autor(es):
Antunes, F. [1] ; Pereira, G. J. [1] ; Jasiulionis, M. G. [1] ; Bincoletto, C. [1] ; Smaili, S. S. [1]
Número total de Autores: 5
Afiliação do(s) autor(es):
[1] Univ Fed Sao Paulo, EPM, Dept Pharmacol, UNIFESP, Rua Tres Maio 100, BR-04044020 Sao Paulo, SP - Brazil
Número total de Afiliações: 1
Tipo de documento: Artigo Científico
Fonte: Chemico-Biological Interactions; v. 281, p. 89-97, FEB 1 2018.
Citações Web of Science: 3
Resumo

Melanoma incidence increases every year worldwide and is responsible for 80% of skin cancer deaths. Due to its metastatic potential and resistance to almost any treatments such as chemo, radio, immune and targeted-therapy, the patients still have a poor prognosis, especially at metastatic stage. Considering that, it is crucial to find new therapeutic approaches to overcome melanoma resistance. Here we investigated the effect of cisplatin (CDDP), one of the chemotherapeutic agents used for melanoma treatment, in association with nutritional deprivation in murine melanoma cell lines. Cell death and autophagy were evaluated after the treatment with cisplatin, nutritional deprivation and its association using an in vitro model of murine melanocytes malignant transformation to metastatic melanoma. Our results showed that nutritional deprivation augmented cell death induced by cisplatin in melanoma cells, especially at the metastatic subtype, with slight effects on melanocytes. Mechanistic studies revealed that although autophagy was present at high levels in basal conditions in melanoma cells, was not essential for cell death process that involved mitochondrial damage, reactive oxygen species production and possible glycolysis inhibition. In conclusion, nutritional shortage in combination with chemotherapeutic drugs as cisplatin can be a valuable new therapeutic strategy to overcome melanoma resistance. (AU)

Processo FAPESP: 12/51215-4 - Autofagia e glicogênio sintase quinase-3 (GSK3) como alvos moleculares capazes de aumentar a atividade de fármacos utilizados no tratamento de leucemias mielóides (aguda e crônica)
Beneficiário:Claudia Bincoletto Trindade
Linha de fomento: Auxílio à Pesquisa - Regular
Processo FAPESP: 13/20073-2 - Estudo da autofagia no processo de proteção celular de ratas senescentes
Beneficiário:Soraya Soubhi Smaili
Linha de fomento: Auxílio à Pesquisa - Regular